Attachment V - Page 1 
GLOSSARY 
ADA 
AZT 
BCG 
BPV 
BRMP 
cDNA 
CF 
CFTR 
CFU 
CSF 
CT 
CTL 
DMRIE 
DOPE 
FACC 
FDA 
GALV 
GC 
GCV 
G-CSF 
GM-CSF 
HIV 
HLA 
HSV-tk 
IL 
IRB 
ml 
MoMuLV 
MRI 
NIH 
neo R 
NIH Guidelines 
OPRR 
ORDA 
Pg 
PGK 
PI 
Points to Consider 
RAC 
RCR 
UCSD 
VPC 
adenosine deaminase 
azidothymidine 
Bacille Calmette-Guerin 
bovine papilloma vims 
Biological Response Modifiers Program 
complementary DNA 
cystic fibrosis 
Cystic Fibrosis Transmembrane Conductance Regulator 
colony forming units 
cerebral spinal fluid 
computerized tomography 
cytotoxic T lymphocyte 
l,2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide 
dioleoylphosphatidylethanolamine 
Fanconi anemia complementation C 
Food and Drug Administration 
gibbon ape leukemia virus 
glucocerebrosidase 
ganciclovir 
granulocyte colony stimulating factor 
granulocyte-macrophage colony stimulating factor 
human immunodeficiency vims 
human leukocyte antigen 
herpes simplex vims thymidine kinase 
interleukin 
Institutional Review Board 
milliliters 
Moloney murine leukemia vims 
magnetic resonance imaging 
National Institutes of Health 
neomycin resistance 
National Institutes of Health Guidelines for Research Involving 
Recombinant DNA Molecules 
Office for the Protection of Research Risks 
Office of Recombinant DNA Activities 
picograms 
phosphoglycerate kinase 
principal investigator 
Points to Consider in the Design and Submission of Protocols for 
the Transfer of Recombinant DNA into the Genome of Human 
Subjects 
Recombinant DNA Advisory Committee 
replication-competent retrovirus 
University of California, San Diego 
vector producing cells 
Recombinant DNA Research, Volume 18 
[589] 
